Index

By TNW

About Index Trending news Pricing

Sign up or sign in

AbbVie

Work at AbbVie? Add yourself to this profile

2977

AbbVie

AbbVie's official global Twitter feed featuring news and updates managed by our global newsroom. Review our Twitter guidelines here on our site

Edit Profile

More info

Elsewhere

Also headquartered in Chicago

Companies in the same industry

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing

Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 4

Acquisitions 1

Apps 5

Employees

Team size

10000+

Locations

HQ

Chicago, United States

Headquarters

More Job Cuts at Infinity As AbbVie Sends Back Blood Cancer Drug

Health

Better Buy: Merck & Co. Inc. vs. AbbVie

Stock markets Health

Better Buy: AbbVie Inc. vs. Johnson & Johnson

AbbVie's Rova-T Update at ASCO: Good or Bad?

Health

3 Reasons to Buy AbbVie Inc.

Is AbbVie's Stock Too Risky?

3 Reasons AbbVie's and Biogen's Latest MS Drug Might Flop

A Heavy Hitter Just Stepped Up to the Cystic Fibrosis Plate

Why June Could Be a Big Month for AbbVie Investors

via ,

Stemcentrx Sale to Return a Record $1.7 Billion for VC Firm Founders Fund

Funding Health

,

Sanofi's Bid for Medivation Is Too Low

$5,800,000,000

, , , +1

AbbVie acquiring cancer drug startup StemcenTrx for $5.8 billion

Health Funding Strategy

Better Buy: Pfizer Inc. vs. AbbVie

Stock markets Health

AbbVie's Venclexta Notches FDA Win, But Investors Might Want To Temper Enthusiasm

Better Buy: AbbVie vs. Johnson & Johnson

AstraZeneca or AbbVie: Which Is Better for Dividend Growth Investors?

AbbVie Inc.'s Big Win Over Gilead Sciences Wasn't in Hepatitis C

Better Buy: AbbVie Inc. vs. Eli Lilly

Health Earnings

Instant Analysis: Regeneron Pharmaceuticals and Sanofi's Experimental Drug Bests an AbbVie Blockbuster

Is This the Company Gilead Sciences Should Fear Most? (Hint: It's Not Merck or AbbVie)